Medicure MCUJF
OTC MCUJF
$1.95 +0.09 (+4.84%)
At close: Sep 28, 2026 · 4:00 PM EDT

Medicure (MCUJF) EBIT Margin (2009 - 2026)

Updated

Medicure (MCUJF) reported EBIT Margin of -18.22% for the quarter ended Jun 30, 2026, down 7.74 percentage points from -10.48% a year earlier and down 87.20 percentage points from the prior quarter.

Analysis

Medicure (MCUJF) EBIT Margin (2009 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Medicure's EBIT Margin came in at 50.18%, up 21.02 percentage points year-over-year; for the year ended Dec 31, 2025, it came in at 4.46%, down 18.86 percentage points from the prior year.

  • EBIT Margin has declined for three consecutive years, though with a five-year change of +74.28 percentage points (years ended Dec 2020 to Dec 2025).
  • By year, EBIT Margin came in at 23.32% in the year ended Dec 31, 2024 (-2.88 pp), 26.20% in the year ended Dec 31, 2023 (-9.10 pp), 35.29% in the year ended Dec 31, 2022 (+44.92 pp) and -9.63% in the year ended Dec 31, 2021 (+60.20 pp).
  • The figure for the quarter ended Jun 30, 2026 ranks as the lowest quarterly EBIT Margin since the quarter ended Jun 30, 2024.
  • Year over year, EBIT Margin gained in four of the last eight quarters, with an average year-over-year change of +8.14 percentage points.
  • The high point for year-over-year EBIT Margin in five years was the quarter ended Sep 30, 2022 (a gain of 120.47 percentage points); the low point was the quarter ended Sep 30, 2023 (a drop of 103.91 percentage points).
  • Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at 68.98% (quarter ended Mar 31, 2026), 81.92% (quarter ended Dec 31, 2025) and 60.94% (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.21%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 37.86%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -3.52%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 20.57%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.95%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 37.40%
10 Medicure 203.51 Mn 195.32 Mn 2.31 Mn -18.22%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -18.22%
Mar 31, 2026 68.98%
Dec 31, 2025 81.92%
Sep 30, 2025 60.94%
Jun 30, 2025 -10.48%
Mar 31, 2025 18.49%
Dec 31, 2024 95.74%
Sep 30, 2024 16.09%
Jun 30, 2024 -21.65%
Mar 31, 2024 33.77%
Dec 31, 2023 114.55%
Sep 30, 2023 1.82%
Jun 30, 2023 5.46%
Mar 31, 2023 103.66%
Dec 31, 2022 114.55%
Sep 30, 2022 105.73%
Jun 30, 2022 -13.29%
Mar 31, 2022 40.82%
Dec 31, 2021 4.84%
Sep 30, 2021 -14.74%
API Access

Medicure EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=MCUJF&period=max&api_key=YOUR_API_KEY